Intellia Therapeutics, Inc is a biotechnology business based in the US. Intellia Therapeutics shares (NTLA) are listed on the NASDAQ and all prices are listed in US Dollars. Intellia Therapeutics employs 312 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Intellia Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NTLA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Intellia Therapeutics stock price (NASDAQ: NTLA)Use our graph to track the performance of NTLA stocks over time.
Intellia Therapeutics shares at a glance
|Latest market close||$74.94|
|52-week range||$17.10 - $202.73|
|50-day moving average||$114.74|
|200-day moving average||$80.29|
|Wall St. target price||$138.44|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.00|
Buy Intellia Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Intellia Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Intellia Therapeutics price performance over time
|1 week (2021-07-16)||N/A|
|1 month (2021-06-25)||-15.64%|
|3 months (2021-04-27)||-13.93%|
|6 months (2021-01-23)||N/A|
|1 year (2020-07-23)||N/A|
|2 years (2019-07-23)||N/A|
|3 years (2018-07-23)||N/A|
|5 years (2016-07-23)||N/A|
Intellia Therapeutics financials
|Revenue TTM||$51.5 million|
|Gross profit TTM||$-92,414,000|
|Return on assets TTM||-18.17%|
|Return on equity TTM||-37.46%|
|Market capitalisation||$10.7 billion|
TTM: trailing 12 months
Shorting Intellia Therapeutics shares
There are currently 4.6 million Intellia Therapeutics shares held short by investors – that's known as Intellia Therapeutics's "short interest". This figure is 23.6% down from 6.1 million last month.
There are a few different ways that this level of interest in shorting Intellia Therapeutics shares can be evaluated.
Intellia Therapeutics's "short interest ratio" (SIR)
Intellia Therapeutics's "short interest ratio" (SIR) is the quantity of Intellia Therapeutics shares currently shorted divided by the average quantity of Intellia Therapeutics shares traded daily (recently around 3.6 million). Intellia Therapeutics's SIR currently stands at 1.27. In other words for every 100,000 Intellia Therapeutics shares traded daily on the market, roughly 1270 shares are currently held short.
However Intellia Therapeutics's short interest can also be evaluated against the total number of Intellia Therapeutics shares, or, against the total number of tradable Intellia Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Intellia Therapeutics's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Intellia Therapeutics shares in existence, roughly 70 shares are currently held short) or 0.0753% of the tradable shares (for every 100,000 tradable Intellia Therapeutics shares, roughly 75 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Intellia Therapeutics.
Find out more about how you can short Intellia Therapeutics stock.
Intellia Therapeutics share dividends
We're not expecting Intellia Therapeutics to pay a dividend over the next 12 months.
Intellia Therapeutics share price volatility
Over the last 12 months, Intellia Therapeutics's shares have ranged in value from as little as $17.1 up to $202.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intellia Therapeutics's is 2.1066. This would suggest that Intellia Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Intellia Therapeutics overview
Intellia Therapeutics, Inc. , a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc.
Stocks similar to Intellia Therapeutics
Intellia Therapeutics in the news
Crispr Therapeutics Represents the Best of Emerging Biotechnology
Biotech Bonanza: Promising Second Half Outlook
Alzheimer's Approval, COVID-19 Vaccines Put Spotlight On Biotech Sector, But What's Next?
Frequently asked questionsWhat percentage of Intellia Therapeutics is owned by insiders or institutions?
Currently 10.122% of Intellia Therapeutics shares are held by insiders and 83.179% by institutions. How many people work for Intellia Therapeutics?
Latest data suggests 312 work at Intellia Therapeutics. When does the fiscal year end for Intellia Therapeutics?
Intellia Therapeutics's fiscal year ends in December. Where is Intellia Therapeutics based?
Intellia Therapeutics's address is: 40 Erie Street, Cambridge, MA, United States, 02139 What is Intellia Therapeutics's ISIN number?
Intellia Therapeutics's international securities identification number is: US45826J1051 What is Intellia Therapeutics's CUSIP number?
Intellia Therapeutics's Committee on Uniform Securities Identification Procedures number is: 45826J105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert